Pramod Yadav, Jubilant Pharma Limited CEO

Ju­bi­lant Hol­lis­ter­Sti­er nets US gov­ern­ment con­tract to in­crease ac­tiv­i­ty at its grow­ing fa­cil­i­ty

A phar­ma­ceu­ti­cal con­tract man­u­fac­tur­er that has been grow­ing its pres­ence in the US has se­cured it­self a siz­able con­tract from the US gov­ern­ment.

Ju­bi­lant Hol­lis­ter­Sti­er, a sub­sidiary of Sin­ga­pore-based Ju­bi­lant Phar­ma Lim­it­ed, has en­tered in­to a co­op­er­a­tive agree­ment for $149.6 mil­lion with the Army Con­tract­ing Com­mand. The deal is al­so in co­or­di­na­tion with the Joint Pro­gram Ex­ec­u­tive Of­fice for Chem­i­cal, Bi­o­log­i­cal, Ra­di­o­log­i­cal and Nu­clear De­fense (JPEO-CBRND) on be­half of BAR­DA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.